Abbott Laboratories vs. Evommune, Inc.
Abbott Laboratories and Evommune, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | EVMN | |
|---|---|---|
| Market Cap | $183.77 billion | $244.25 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | EVMN | |
|---|---|---|
| Dividend Yield | 2.37% | — |
ABT and EVMN split the dividend factors evenly.
Risk & Sentiment
| ABT | EVMN | |
|---|---|---|
| Short Interest | 0.57% | 0.28% |
EVMN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, EVMN overview, EVMN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.